W. How et al., VIRAL NUCLEOTIDE CHANGES IN ASYMPTOMATIC HEPATITIS-B CARRIERS UNDERGOING INTERFERON TREATMENT, Alimentary pharmacology & therapeutics, 10(2), 1996, pp. 199-202
Background: Interferon might induce mutation in regions of hepatitis B
virus DNA that encode for immunologic target of cytotoxic T lymphocyt
es. Aim: To investigate the short-term effect of steroid priming and i
nterferon therapy on hepatitis B virus, we followed the nucleotide cha
nges in the precore and core region of hepatitis B virus DNA in seven
healthy asymptomatic carriers who underwent steroid priming followed b
y recombinant alpha interferon for 3 months. Methods: Hepatitis B viru
s DNA from serial sera of the patients were polymerase chain reaction-
amplified, and the precore and core region directly sequenced and anal
ysed. Results: Analysis revealed no serial changes in the hepatitis B
virus nucleotide sequence in any of the patients. Conclusions: Steroid
priming and short-term treatment with interferon in healthy asymptoma
tic patients does not select for hepatitis B virus with mutations in t
he precore and core region.